“【Re

This seminar focuses on the complexities of M&A and business succession within the unique legal structure of medical corporations, and the differences compared to business companies. Unlike for-profit business companies, medical corporations have unique succession schemes due to restrictions on the transfer of equity interests. Legal procedures such as approval by the general meeting of members, resolution by the board of directors, and notification to the regional bureau are also complex. This seminar is highly beneficial for executives and successors of medical institutions as it clarifies the specific challenges of medical corporations and the points to note in M&A with business companies.

In the context of medical M&A and business succession, understanding this "uniqueness" is key to achieving a smooth transaction. The transferring party needs to find a successor that can maintain and develop its corporate status and medical care system, while the receiving party needs a strategy to improve management and expand business while complying with medical corporation regulations. It is essential to flexibly consider schemes such as "loans to the medical corporation" or "refund of funds" as alternatives to equity interests, or the transfer of "member" qualifications of the medical corporation, depending on the specific individual circumstances.

For executives of medical institutions and those facing succession issues, the "early consultation with experts" is highlighted as important. M&A of medical corporations requires more specialized knowledge and experience than general business succession. Understanding the unique issues of special corporations, as explained in this seminar, and accurately grasping your own institution's situation, makes early collaboration with experts such as M&A support organizations and tax accountants the fastest path to success. Even when considering closure, we hope you will recognize that business succession can be an option to contribute to regional healthcare.